Mintz Levin's Joel Papernik on biotech M&A_Merrill DataSite - Virtual Data Room Services

Visite www.datasite.com for more information about our product virtual data room. "Hordes of cash by Big Pharma and the larger biotech companies have accumulated, and now that healthcare reform is behind us, they've got a bit more confidence, and they want to fill in their pipeline and be in control of the FDA process," says Joel Papernik, a partner at Mintz Levin in The Deal's video. "They have a lot of motivation to buy right now," including the expiration of many patents, he says. The interview with Papernik is part of our special series on Faces of the Middle Market. Read the full story in The Deal magazine, watch the videos, listen to the podcasts and read the white papers. Watch the interview with Papernik below or download it on iTunes.
- Mary Kathleen Flynn

Category:

Science & Technology

Tags:

• financial due diligence
• due diligence checklist
• acquisition strategies
• acquisition checklist
• acquisition due diligence
• virtual data room
• virtual data rooms
• virtual data room services
• virtual data room provide
• virtual data room providers